RxDoctor Payments Data

Robert Hieger, MD

Family Medicine · Festus, MONPI 1801328612

Payments from drug & device makers

$6,769in general payments, 2019–2025

Across 382 payments — averaging $17.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$821
  • Novo Nordisk$588
  • Lilly USA, LLC$512
  • Pfizer$418
  • Sumitomo Pharma America, Inc.$250
  • plus $2K from 34 others

What the payments were for

  • Food & beverage$6,764100%
  • Education$50%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,769 in reported general payments places this provider in the 90th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$66,289
Medicare patients
203
Services billed
1,424

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enbrel SureclickEtanercept12$88,490
EliquisApixaban84$74,195
Trelegy ElliptaFluticasone/Umeclidin/Vilanter81$68,526
OzempicSemaglutide49$62,849
TrulicityDulaglutide43$51,988
JardianceEmpagliflozin27$40,691
JanuviaSitagliptin Phosphate14$33,835
FarxigaDapagliflozin Propanediol37$32,375
GemtesaVibegron42$29,941
LinzessLinaclotide39$22,736
XareltoRivaroxaban30$22,060
MounjaroTirzepatide20$22,015
Spiriva HandihalerTiotropium Bromide32$19,895
MyrbetriqMirabegron30$19,306
Repatha SureclickEvolocumab15$18,787

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta, Arexvy$125$94,614142 claims
PfizerEliquis, Abrysvo$418$80,937108 claims
Novo NordiskOzempic, Wegovy$588$79,25561 claims
Lilly USA, LLCTrulicity, Mounjaro$512$74,00363 claims
Boehringer IngelheimJardiance, Combivent Respimat$81$49,62239 claims
AstraZenecaFarxiga, Symbicort$821$37,00357 claims
MerckJanuvia$114$33,83514 claims
Sumitomo Pharma America, Inc.Gemtesa$250$29,94142 claims
AbbVieLinzess$1,942$22,73639 claims
Johnson & JohnsonXarelto$83$22,06030 claims
Astellas Pharma US IncMyrbetriq$122$19,30630 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Festus

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →